ArticleTranslational cancer research2025

Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models.

Rajashree Patnaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.